X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1038) 1038
Publication (56) 56
Newsletter (26) 26
Book Review (20) 20
Magazine Article (6) 6
Book Chapter (4) 4
Conference Proceeding (1) 1
Data Set (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (781) 781
male (561) 561
female (493) 493
nortriptyline (491) 491
adult (322) 322
middle aged (313) 313
nortriptyline - administration & dosage (283) 283
psychiatry (274) 274
nortriptyline - therapeutic use (261) 261
aged (250) 250
pharmacology & pharmacy (246) 246
nortriptyline - blood (210) 210
animals (200) 200
index medicus (196) 196
depressive disorder - drug therapy (186) 186
antidepressants (176) 176
treatment outcome (152) 152
amitriptyline (141) 141
dose-response relationship, drug (139) 139
nortriptyline - pharmacology (139) 139
depression - drug therapy (122) 122
rats (120) 120
nortriptyline - adverse effects (115) 115
antidepressive agents, tricyclic - therapeutic use (112) 112
amitriptyline - administration & dosage (108) 108
antidepressive agents - therapeutic use (105) 105
double-blind method (100) 100
adolescent (98) 98
amitriptyline - blood (98) 98
neurosciences (97) 97
time factors (97) 97
antidepressive agents, tricyclic - administration & dosage (96) 96
drug administration schedule (96) 96
depression (93) 93
major depression (91) 91
clinical neurology (89) 89
nortriptyline - metabolism (86) 86
drug therapy, combination (84) 84
kinetics (81) 81
research (79) 79
depressive disorder - psychology (78) 78
drug therapy (74) 74
imipramine (74) 74
double-blind (73) 73
psychiatric status rating scales (72) 72
fluoxetine (71) 71
nortriptyline - pharmacokinetics (71) 71
depression, mental (70) 70
tricyclic antidepressants (70) 70
antidepressive agents, tricyclic - adverse effects (69) 69
antidepressive agents - administration & dosage (68) 68
pharmacokinetics (68) 68
administration, oral (67) 67
aged, 80 and over (65) 65
depressive disorder, major - drug therapy (64) 64
drug interactions (62) 62
mice (59) 59
clinical trials as topic (58) 58
dosage and administration (58) 58
drugs (56) 56
amitriptyline - therapeutic use (53) 53
antidepressive agents, tricyclic - pharmacokinetics (52) 52
paroxetine (52) 52
analysis (51) 51
serotonin uptake inhibitors - therapeutic use (51) 51
antidepressive agents - adverse effects (49) 49
amitriptyline - pharmacokinetics (48) 48
antidepressive agents, tricyclic - pharmacology (47) 47
age factors (46) 46
amitriptyline - pharmacology (45) 45
antidepressive agents - pharmacology (45) 45
half-life (44) 44
care and treatment (43) 43
antidepressive agents, tricyclic - blood (42) 42
desipramine (42) 42
smoking cessation (42) 42
smoking cessation - methods (41) 41
efficacy (40) 40
follow-up studies (40) 40
health aspects (40) 40
bupropion - therapeutic use (39) 39
child (39) 39
placebo (39) 39
sertraline (39) 39
amitriptyline - metabolism (37) 37
depressive disorder - blood (37) 37
therapy (37) 37
desipramine - pharmacology (36) 36
medicine & public health (36) 36
antidepressive agents, second-generation - therapeutic use (35) 35
j ve psychiatry (35) 35
medicine, general & internal (35) 35
pharmacotherapy (35) 35
toxicology (35) 35
brain - metabolism (34) 34
risk factors (34) 34
antidepressant (33) 33
bupropion (33) 33
depressive disorder - diagnosis (33) 33
hydroxylation (33) 33
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1027) 1027
German (12) 12
Danish (6) 6
French (6) 6
Italian (4) 4
Spanish (4) 4
Japanese (3) 3
Russian (3) 3
Chinese (2) 2
Polish (2) 2
Norwegian (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2016, Volume 388, Issue 10047, pp. 881 - 890
Summary Background Major depressive disorder is one of the most common mental disorders in children and adolescents. However, whether to use pharmacological... 
Internal Medicine | TRIALS | MEDICINE, GENERAL & INTERNAL | ACCEPTABILITY | MENTAL-HEALTH-CARE | TRENDS | GUIDELINES | Mianserin - adverse effects | Triazoles - administration & dosage | Triazoles - adverse effects | Humans | Citalopram - adverse effects | Sertraline - adverse effects | Venlafaxine Hydrochloride - adverse effects | Imipramine - administration & dosage | Paroxetine - adverse effects | Mianserin - analogs & derivatives | Paroxetine - administration & dosage | Desipramine - adverse effects | Nortriptyline - administration & dosage | Nortriptyline - adverse effects | Mianserin - administration & dosage | Child | Fluoxetine - adverse effects | Depressive Disorder, Major - drug therapy | Clomipramine - administration & dosage | Duloxetine Hydrochloride - adverse effects | Double-Blind Method | Drug Administration Schedule | Treatment Outcome | Clomipramine - adverse effects | Evidence-Based Medicine | Desipramine - administration & dosage | Randomized Controlled Trials as Topic | Venlafaxine Hydrochloride - administration & dosage | Citalopram - administration & dosage | Confounding Factors (Epidemiology) | Sertraline - administration & dosage | Adolescent | Amitriptyline - adverse effects | Bayes Theorem | Fluoxetine - administration & dosage | Duloxetine Hydrochloride - administration & dosage | Antidepressive Agents - administration & dosage | Antidepressive Agents - adverse effects | Research Design | Amitriptyline - administration & dosage | Imipramine - adverse effects | Psychological aspects | Medical colleges | Neurosciences | Drugs and youth | Rankings | Comparative analysis | Child psychopathology | Major depressive disorder | Antidepressants, Tricyclic | Pediatric pharmacology | Mental illness | Studies | Teenagers | Mental depression | Antidepressants | Meta-analysis | Children & youth
Journal Article
Neuroscience Letters, ISSN 0304-3940, 11/2017, Volume 660, pp. 79 - 85
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 01/2018, Volume 269, pp. 266 - 276
Cytosolic delivery remains a major bottleneck for siRNA therapeutics. To facilitate delivery, siRNAs are often enclosed in nanoparticles (NPs). However, upon... 
Nanogels | Lysosomal membrane permeabilization | Drug repurposing | siRNA delivery | Cationic amphiphilic drugs | Phospholipidosis | LIPID NANOPARTICLES | VOLUME | DEATH | CHEMISTRY, MULTIDISCIPLINARY | ENDOSOMAL ESCAPE | DELIVERY | LOADED DEXTRAN NANOGELS | SMALL INTERFERING RNA | LUNG-CANCER | PHARMACOLOGY & PHARMACY | ACID SPHINGOMYELINASE | MEMBRANE PERMEABILIZATION | Loratadine - administration & dosage | Gels | Fluorescein-5-isothiocyanate - administration & dosage | Humans | Protein-Serine-Threonine Kinases - genetics | Fluorescein-5-isothiocyanate - analogs & derivatives | Proto-Oncogene Proteins - genetics | Green Fluorescent Proteins - genetics | Salmeterol Xinafoate - administration & dosage | Lysosomes - metabolism | Nortriptyline - administration & dosage | Transfection | Carvedilol - administration & dosage | Cell Cycle Proteins - genetics | Cell Line, Tumor | Loratadine - analogs & derivatives | Nanoparticles - administration & dosage | Oligonucleotides - administration & dosage | RNA, Small Interfering - administration & dosage | Dextrans - administration & dosage | Adjuvants, Pharmaceutic - administration & dosage | Drugs | Drug delivery systems | Biological products | Therapeutics | Genetic engineering | Drug approval | Vehicles | Homeopathy | Materia medica and therapeutics | Life Sciences | Pharmaceutical sciences | Cancer
Journal Article
Anesthesiology, ISSN 0003-3022, 11/2014, Volume 121, Issue 5, pp. 1045 - 1055
Journal Article
Neurology, ISSN 0028-3878, 04/2012, Volume 78, Issue 16, pp. 1229 - 1236
Journal Article
Journal Article
Pharmacogenetics and Genomics, ISSN 1744-6872, 09/2013, Volume 23, Issue 9, pp. 494 - 497
Journal Article
Journal Article
JAMA, ISSN 0098-7484, 01/1998, Volume 279, Issue 4, pp. 287 - 291
CONTEXT.— Depression and ischemic heart disease often are comorbid conditions and, in patients who have had a myocardial infarction, the presence of depression... 
ARRHYTHMIA SUPPRESSION TRIAL | MEDICINE, GENERAL & INTERNAL | RATE-VARIABILITY | TRICYCLIC ANTIDEPRESSANTS | DESIPRAMINE | MYOCARDIAL-INFARCTION | INCREASED MORTALITY | CARDIAC PATIENTS | IMIPRAMINE | ASSOCIATION | FLUOXETINE | Antidepressive Agents, Second-Generation - adverse effects | Humans | Middle Aged | Depressive Disorder - drug therapy | Male | Paroxetine - therapeutic use | Antidepressive Agents, Second-Generation - administration & dosage | Antidepressive Agents, Second-Generation - therapeutic use | Paroxetine - adverse effects | Nortriptyline - therapeutic use | Paroxetine - administration & dosage | Heart Rate - drug effects | Psychiatric Status Rating Scales | Nortriptyline - administration & dosage | Nortriptyline - adverse effects | Female | Heart Function Tests | Antidepressive Agents, Tricyclic - administration & dosage | Adrenergic Uptake Inhibitors - adverse effects | Adrenergic Uptake Inhibitors - therapeutic use | Double-Blind Method | Drug Administration Schedule | Serotonin Uptake Inhibitors - therapeutic use | Serotonin Uptake Inhibitors - adverse effects | Antidepressive Agents, Tricyclic - therapeutic use | Depressive Disorder - complications | Serotonin Uptake Inhibitors - administration & dosage | Myocardial Ischemia - complications | Antidepressive Agents, Tricyclic - adverse effects | Adrenergic Uptake Inhibitors - administration & dosage | Aged | Heart | Paroxetine | Evaluation | Nortriptyline | Drug therapy | Depression, Mental | Cardiovascular disease | Mental depression | Antidepressants
Journal Article
Lancet, The, ISSN 0140-6736, 2009, Volume 374, Issue 9697, pp. 1252 - 1261
Journal Article
Journal Article